• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

NEUROSOUND: SEQUENCING THERAPIES IN MULTIPLE SCLEROSIS

December 27, 2017  

Long-term efficacy, safety of DMTs in MS

December 20, 2017  

MS Sequencing: Part 8 – MS therapies in practice: Reader survey results

December 7, 2017  

Cladribine tablets (Mavenclad) approved in Canada for RRMS

December 4, 2017  

Cladribine tablets – Updated efficacy and safety results

November 28, 2017  

ECTRIMS 2017 SLIDE DECK

November 9, 2017  

ECTRIMS 2017 DAILY REPORT – SATURDAY EDITION

October 28, 2017  

ECTRIMS 2017 DAILY REPORT – FRIDAY EDITION

October 27, 2017  

ECTRIMS 2017 DAILY REPORT – THURSDAY EDITION

October 26, 2017  

MS Sequencing Part 7: What is a rational approach?

October 17, 2017  
Previous
25
26
27
28
29
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Anti-CD20 therapy in MS: comparing efficacy and safety posted on July 21, 2026
  • Highlights of EAN 2026 – Part 1 posted on June 30, 2026
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions